Dentsply Sirona topped Q1 estimates, raised 2025 sales outlook, and reaffirmed EPS guidance, pushing shares higher despite ...

Analysts' ratings for Dentsply Sirona XRAY over the last quarter vary from bullish to bearish, as provided by 9 analysts. The table below provides a concise overview of recent ratings by analysts ...

Our free stock report includes 1 warning sign investors should be aware of before investing in DENTSPLY SIRONA. Read for free now. Revenue exceeded analyst estimates by 2.9%. Earnings per share ...

Welcome to the Q1 2025 Dentsply Sirona Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer ...

CHARLOTTE, N.C., May 08, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced its financial results for the first quarter of 2025.

Access our full analysis report here, it’s free. Dental Equipment & Technology company Dentsply Sirona (NASDAQ:XRAY) jumped 6%. Is now the time to buy Dentsply Sirona? Access our full analysis ...

Ooops... Something went wrong while loading this page.

Dentsply raised its 2025 sales guidance to $3.6 billion to $3.7 billion, from $3.5 billion to $3.6 billion, due to changes in foreign exchange rates. Analysts are expecting 2025 sales of $3.58 billion ...

We recently published a list of Smart Money Ratings For 20 Most Undervalued Stocks. In this article, we are going to take a ...

In this article, we are going to take a look at where Dentsply Sirona Inc. (NASDAQ:XRAY) stands against other Thursday’s top-performing stocks. The stock market extended its winning streak on ...

Dental products company Dentsply Sirona (NASDAQ:XRAY) announced in Q1 CY2025, but sales fell by 7.8% year on year to $879 ...